Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satraplatin and Prednisone in Metastatic Androgen Independent Prostate Cancer
NCT00634647Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2008
- Primary completion
- Feb 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of satraplatin in prostate cancer (PCa), sponsored by National Cancer Institute. Started Feb 2008; status: completed.
02
Drugs
satraplatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00634647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634647.